The Nucleus® Hybrid™ L24 Implant System New Enrollment Study
Posted Date: Nov 2, 2021
- Investigator: Ravi Samy
- Specialties:
- Type of Study: Device
The purpose of the Nucleus Hybrid L24 Implant System: New Enrollment Study is to gather long term safety and effectiveness data on the approved device. This real world experience may allow further learning about sub-groups of patients, evaluate training programs, and further explore the type and frequency of adverse events in a long term format.
Criteria:
The Nucleus Hybrid L24 Implant System Is Indicated For Unilateral Use In Patients Aged 18 Years And Older Who Have Residual Low Frequency Hearing Sensitivity And Severe To Profound Highfrequency Sensorineural Hearing Loss, And Who Obtain Limited Benefit F
Keywords:
Cochlear Implant, Hearing Loss, Nucleus Hybrid L24
For More Information:
Lisa Wenstrup, Aud
513-475-8453
houstola@ucmail.uc.edu